Meningococcal polysaccharide-protein conjugate vaccines. (Q35994212)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15620558 AND SRC:MED&resulttype=core&format=json

6 January 2020

review article

1 reference

title

Meningococcal polysaccharide-protein conjugate vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15620558 AND SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15620558 AND SRC:MED&resulttype=core&format=json

6 January 2020

2

Andrew J Pollard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15620558 AND SRC:MED&resulttype=core&format=json

6 January 2020

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15620558 AND SRC:MED&resulttype=core&format=json

Lancet Infectious Diseases

6 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15620558 AND SRC:MED&resulttype=core&format=json

6 January 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15620558 AND SRC:MED&resulttype=core&format=json

6 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15620558 AND SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

21-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15620558 AND SRC:MED&resulttype=core&format=json

Letter: Recognition of diphtheria

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Genetic characterization of a new variant within the ET-37 complex of Neisseria meningitidis associated with outbreaks in various parts of the world

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Phenotypic and genotypic approaches to characterization of isolates of Neisseria meningitidis from patients and their close family contacts.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Multi-locus sequence typing: a tool for global epidemiology

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

The evolving epidemiology of invasive meningococcal disease: a two-year prospective, population-based study in children in the area of Athens

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Recent emergence of serogroup C meningococcal disease in Greece

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Serogroup C meningococcal outbreaks in the United States. An emerging threat

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Carriage of a new epidemic strain of Neisseria meningitidis and its relationship with the incidence of meningococcal disease in Galicia, Spain

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Increasing incidence of meningococcal disease in Spain associated with a new variant of serogroup C

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

The epidemic wave of meningococcal disease in Spain in 1996-1997: probably a consequence of strain displacement

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Serotype Distribution, Antibiotic Susceptibility, and Genetic Relatedness of Neisseria meningitidis Strains Recently Isolated in Italy

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : V. THE IMMUNOLOGICAL SPECIFITY OF AN ANTIGEN PREPARED BY COMBINING THE CAPSULAR POLYSACCHARIDE OF TYPE III PNEUMOCOCCUS WITH FOREIGN PROTEIN.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Haemophilus influenzae type b conjugate vaccines: a review of efficacy data

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Human immunity to the meningococcus. I. The role of humoral antibodies

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Age dependence of in vitro survival of meningococci in whole blood during childhood

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Induction of immunological memory in UK infants by a meningococcal A/C conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

A randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Safety and immunogenicity of three lots of meningococcal serogroup C conjugate vaccine administered at 2, 3 and 4 months of age

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Prevalence of de-O-acetylated serogroup C meningococci before the introduction of meningococcal serogroup C conjugate vaccines in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinees and carriers.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Effectiveness of meningococcal C conjugate vaccine in teenagers in England

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Impact of meningococcal C conjugate vaccine in the UK.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to healthy four-year-old children

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Safety of a new conjugate meningococcal C vaccine in infants

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Dramatic decline of serogroup C meningococcal disease in Catalonia (Spain) after a mass vaccination campaign with meningococcal C conjugated vaccine

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Cost-effectiveness of immunization strategies for the control of serogroup C meningococcal disease

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Capsule switching of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Rapid serogroup switching in Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Serogroup B, Electrophoretic Type 15Neisseria meningitidisin Canada

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Microevolution through DNA exchange among strains of Neisseria meningitidis isolated during an outbreak in the Czech Republic

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

First report of capsule replacement among electrophoretic type 37 Neisseria meningitidis strains in Italy

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Serogroup W135 meningococcal disease in Hajj pilgrims.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Meningococcal vaccines: advances but new questions?

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Positive effect of meningococcal C vaccination on serogroup replacement in Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Capsule switching among C:2b:P1.2,5 meningococcal epidemic strains after mass immunization campaign, Spain

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Meningococcal conjugate vaccines: new opportunities and new challenges

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdom

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Neisseria meningitidis Carriage during an Outbreak of Serogroup C Disease

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Invasive meningococcal and pneumococcal disease in Switzerland: cost?utility analysis of different vaccine strategies

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Vaccine prevention of meningococcal disease, coming soon?

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Epidemic meningococcal disease in sub-Saharan Africa--towards a sustainable solution?

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Serogroup W-135 meningococcal disease during the Hajj, 2000

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Meningococcal disease and vaccination in North America.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitidis-diphtheria toxoid conjugate vaccine and by a polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Safety and immunogenicity of three doses of a Neisseria meningitidis A C diphtheria conjugate vaccine in infants from Niger

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Immunogenicity and immunological priming of the serogroup a portion of a bivalent meningococcal A/C conjugate vaccine in 2-year-old children

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Dose escalation, safety and immunogenicity study of a tetravalent meninogococcal polysaccharide diphtheria conjugate vaccine in toddlers

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(04)01251-4

7 January 2021

10.1016/S1473-3099(04)01251-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15620558 AND SRC:MED&resulttype=core&format=json

6 January 2020

1 reference